Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
Retardancy self-sustaining drug delivery
Document Type and Number:
Japanese Patent JP6162196
Kind Code:
B2
Abstract:
In one aspect, the present invention is concerned with a treatment where it is desired that an active agent is designed to be released in a prolonged manner at a time point some time after administration of the active agent. The present invention is particularly suited to administering an agent which may be released whilst a subject is sleeping, shortly before waking and continues to administer the drug during the early waking hours. As well as treating certain conditions by a particular regime, the invention also provides novel formulations for a delayed, followed by a prolonged release of drug.

Inventors:
Mullen alexander
Stevens Howard
Eccleston Sara
Application Number:
JP2015219313A
Publication Date:
July 12, 2017
Filing Date:
November 09, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
University of Strathclyde
International Classes:
A61K9/42; A61K31/277; A61K45/00; A61K47/14; A61K47/38; A61K47/44; A61P9/00
Domestic Patent References:
JP2005508326A
JP2004300148A
JP2005508327A
JP2001322927A
JP2001328948A
JP2000103731A
JP2000281564A
Foreign References:
WO2008081891A1
Other References:
GHIMIRE,IN-VITRO/IN-VIVO CORRELATION OF PULSATILE GRUG RELEASE FROM PRESS-COATED TABLET 以下備考,EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS,NL,ELSEVIER SCIENCE PUBLISHERS B.V.,2007年 8月 8日,V67 N2,P515-523,FORMULATIONS: A PHARMACOSCINTIGRAPHIC STUDY IN THE BEAGLE DOG
Attorney, Agent or Firm:
Takaki Nishijima
Disciple Maru Ken
Shinichiro Tanaka
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Satsuki Ichikawa
Tomoyuki Iwasawa